Inactive Instrument

Analyst Reco. CM LIFE28 Nasdaq

Equities

Jefferies Downgrades SomaLogic to Hold From Buy, Adjusts Price Target to $2.30 From $3.50	05/10/23	MT
Canaccord Genuity Downgrades SomaLogic to Hold From Buy, Cuts Price Target to $2.50 From $5	25/09/23	MT
Canaccord Genuity Adjusts Price Target on SomaLogic to $5 From $6, Maintains Buy Rating	29/03/23	MT
Stifel Nicolaus Adjusts SomaLogic Price Target to $8 From $12, Maintains Buy Rating	16/08/22	MT
Cowen Adjusts SomaLogic's Price Target to $9 From $11, Keeps Outperform Rating	16/08/22	MT
Cowen Lowers SomaLogic's Price Target to $11 From $14, Maintains Outperform Rating	23/06/22	MT
Canaccord Genuity Lowers SomaLogic's Price Target to $15 From $19, Maintains Buy Rating	13/05/22	MT
Stifel Initiates Coverage on SomaLogic With Buy Rating, $12 Price Target	01/02/22	MT
Canaccord Genuity Starts SomaLogic at Buy With $19 Price Target	14/12/21	MT
Jefferies Starts SomaLogic at Buy With $16 Price Target	10/12/21	MT
Cowen Starts SomaLogic at Outperform With $18 Price Target	23/11/21	MT

No results for this search